Results 41 to 50 of about 10,705 (179)

Severe Chlamydia psittaci pneumonia complicated by deep vein thrombosis: a case report and literature review

open access: yesFrontiers in Medicine
Psittacosis is a zoonotic disease caused by Chlamydia psittaci, primarily transmitted through the respiratory tract. In humans, the most frequently associated condition is atypical pneumonia, while Chlamydia psittaci remains a relatively uncommon ...
Mengdie Chen   +7 more
doaj   +1 more source

A Family Outbreak of Chlamydia psittaci Infection

open access: yesJournal of the Japanese Association for Infectious Diseases, 1996
A family outbreak (3 cases) of Chlamydia psittaci infection was reported. The first case, a 56-year-old man was admitted with fever and general fatigue. Chest X-ray film revealed a consolidation in the right lower lung. One month before admission he had purchased 2 parakeets (chick) and one parakeet died.
Y, Miyashita, Y, Nakamori
openaire   +3 more sources

Omadacycline treatment of severe Chlamydia psittaci pneumonia with septic shock diagnosed via metagenomic next-generation sequencing

open access: yesJournal of Infection in Developing Countries
Introduction: Parrot fever, caused by Chlamydia psittaci, is a zoonotic disease typically treated with tetracyclines. Omadacycline, a novel aminomethyl tetracycline, has limited reports on its efficacy in severe Chlamydia psittaci pneumonia in the ...
Ping Xu, Zhitong Huang
doaj   +1 more source

Comparative Analysis of Chlamydia psittaci Genomes Reveals the Recent Emergence of a Pathogenic Lineage with a Broad Host Range

open access: yesmBio, 2013
Chlamydia psittaci is an obligate intracellular bacterium. Interest in Chlamydia stems from its high degree of virulence as an intestinal and pulmonary pathogen across a broad range of animals, including humans. C.
Timothy D. Read   +5 more
doaj   +1 more source

Polymorphic Membrane Protein 17G of Chlamydia psittaci Mediated the Binding and Invasion of Bacteria to Host Cells by Interacting and Activating EGFR of the Host

open access: yesFrontiers in Immunology, 2022
Chlamydia psittaci (C. psittaci) is an obligate intracellular, gram-negative bacterium, and mainly causes systemic disease in psittacine birds, domestic poultry, and wild fowl.
Xiaohui Li   +5 more
doaj   +1 more source

Evaluation of clinical characteristics and risk factors associated with Chlamydia psittaci infection based on metagenomic next-generation sequencing

open access: yesBMC Microbiology
Introduction Psittacosis is a zoonosis caused by Chlamydia psittaci, the clinical manifestations of Psittacosis range from mild illness to fulminant severe pneumonia with multiple organ failure.
Lei Yuan   +5 more
doaj   +1 more source

A Genomic Catalog of Migratory Microbiomes from Wild Birds across China's Habitats

open access: yesAdvanced Science, Volume 13, Issue 26, 8 May 2026.
ABSTRACT Migratory birds play an important role in the spread of antimicrobial resistance (AMR); however, gaps in surveillance data from vital regions along migratory flyways across China limit the detection of emergent threats. Here, we assembled 340 metagenomes from 52 bird species covering 11 provincial administrative districts in China, presenting ...
Yanan Wang   +13 more
wiley   +1 more source

Clinical characteristics of Chlamydia psittaci pneumonia and predictors analysis of severe patients: a retrospective observational study

open access: yesFrontiers in Medicine
BackgroundWith this study, we aimed to explore the clinical features, laboratory examinations, imaging features, and severe predictors of Chlamydia psittaci pneumonia to identify the disease early, shorten the course of illness, and improve prognosis ...
Ling Wu   +5 more
doaj   +1 more source

Detection of Chlamydia psittaci by Immunofluorescence

open access: yesApplied Microbiology, 1972
A direct fluorescent-antibody (FA) test was developed to detect Chlamydia psittaci in dural impressions from specimen-inoculated mice. Technical procedures for the test were compared. C.
V J, Lewis   +2 more
openaire   +2 more sources

Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous–venous extracorporeal membrane oxygenation (VV‐ECMO): A case report

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1487-1492, May 2026.
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy